“…These include increased age, increased duration of diabetes, poor blood glycemic control, systemic hypertension, renal disease, and dyslipidemia (1). Certain systemic medications have also been hypothesized to have an impact on diabetic macular edema, including angiotensin-converting enzyme (ACE) inhibitors (3,4) and glitazones (5,6). Certain topical medications have also been implicated in the development of macular edema, namely the ocular hypotensive lipids (OHL) (8)(9)(10)(11).…”